travoprost 0.04 MG/ML Ophthalmic Solution [Travatan]

Known as: Travatan Z 0.004 % Ophthalmic Solution, TRAVOPROST 0.04 mg in 1 mL OPHTHALMIC SOLUTION [Travatan Z], TRAVOPROST 0.04 mg in 1 mL OPHTHALMIC SOLUTION/ DROPS [Travatan Z] 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2003-2017
0120032017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
PURPOSE To assess ocular surface changes in participants using latanoprost with benzalkonium chloride (Xalatan) and travoprost… (More)
Is this relevant?
2014
2014
PURPOSE The benzalkonium chloride (BAK) content of tafluprost ophthalmic solution (Tapros(®): tafluprost) has been reduced to… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2012
2012
OBJECTIVES Benzalkonium chloride (BAK)-free travoprost 0.004% (Travatan Z(®), Alcon Laboratories, Inc, Fort Worth, TX) is a new… (More)
  • table 1
  • figure 1
  • figure 2
Is this relevant?
2003
2003
PURPOSE The prostaglandin analogues represent the first option for the treatment of primary open angle glaucoma. The aim of this… (More)
Is this relevant?